EUVIMEDEUVIMED entdecken
Crossref

Delivery of small interfering ribonucleic acid using lipid nanoparticles prepared with pH-responsive dipeptide-conjugated lipids

Katsuki Matayoshi, Furan Song, Hiroyuki Koide, Sei Yonezawa, Chiori Nitta, Masako Okada, Nahoko Ozaki, Makiko Kurata, Tomohiro Asai

Biochemical and Biophysical Research Communications · 2024-10 · 729 · 150372

DOI: 10.1016/j.bbrc.2024.150372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-10. Verfasst von Katsuki Matayoshi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8526, Ja…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Nanoparticles, Lipids, Dipeptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of lipid nanoparticles (LNPs) has enabled the clinical application of small interfering ribonucleic acid (siRNA)-based therapies. Accordingly, various unique ionizable lipids have been explored for efficient siRNA delivery. However, safety concerns related to the structure of ionizable lipids have been raised. Here, we developed a pH-responsive dipeptide-conjugated lipid (DPL) for efficient, high safety siRNA delivery. We synthesized a DPL library by varying the dipeptide sequence and established a strong correlation between the knockdown efficiency of the DPL-based LNPs and the dipeptide sequence. The LNPs prepared with a DPL containing arginine (R) and glutamic acid (E) (DPL-ER) exhibited the highest knockdown efficiency. In addition, the DPL-ER-based LNPs with relatively long lipid tails (DPL-ER-C22:C22) exhibited a higher knockdown efficiency than those with short ones (DPL-ER-18:C18). The zeta potential of the DPL-ER-C22:C22-based LNPs increased as the pH decreased from 7.4 (physiological condition) to 5.5 (endosomal condition). Importantly, the DPL-ER-C22:C22-based LNPs exhibited a higher knockdown efficiency than the LNPs prepared using commercially available ionizable lipids. These results suggest that the DPL-based LNPs are safe and efficient siRNA delivery carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingNanoparticlesLipidsDipeptidesHydrogen-Ion ConcentrationHumansHeLa Cells

Stichwörter der Autor:innen

Amino acidsDipeptide-conjugated lipidLipid nanoparticlesSmall interfering RNA delivery

Substanzen

RNA, Small InterferingLipidsDipeptides

Autor:innen und Institutionen

  • Laboratory of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8526, Japan.
  • Development & Technical Group, Sogo Pharmaceuticals Co., Ltd., 408-1 Sonegasaki, Kamisokoino, Nakama, Fukuoka, 809-0003, Japan.
  • Laboratory of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8526, Japan. Electronic address: asai@u-shizuoka-ken.ac.jp.

Zitieren

APA

Matayoshi, K., Song, F., Koide, H., Yonezawa, S., Nitta, C., Okada, M., Ozaki, N., Kurata, M., & Asai, T. (2024). Delivery of small interfering ribonucleic acid using lipid nanoparticles prepared with pH-responsive dipeptide-conjugated lipids. Biochemical and Biophysical Research Communications, 729, 150372. https://doi.org/10.1016/j.bbrc.2024.150372

Vancouver

Matayoshi K, Song F, Koide H, Yonezawa S, Nitta C, Okada M, et al. Delivery of small interfering ribonucleic acid using lipid nanoparticles prepared with pH-responsive dipeptide-conjugated lipids. Biochemical and Biophysical Research Communications. 2024;729:150372. doi:10.1016/j.bbrc.2024.150372

BibTeX
@article{Matayoshi2024,
  author = {Matayoshi, Katsuki and Song, Furan and Koide, Hiroyuki and Yonezawa, Sei and Nitta, Chiori and Okada, Masako and Ozaki, Nahoko and Kurata, Makiko and Asai, Tomohiro},
  title = {Delivery of small interfering ribonucleic acid using lipid nanoparticles prepared with pH-responsive dipeptide-conjugated lipids},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  volume = {729},
  pages = {150372},
  doi = {10.1016/j.bbrc.2024.150372}
}
Kostenlos starten →